Inhibition of α-Synuclein Aggregation and Mature Fibril Disassembling With a Minimalistic Compound, ZPDm
出版年份 2020 全文链接
标题
Inhibition of α-Synuclein Aggregation and Mature Fibril Disassembling With a Minimalistic Compound, ZPDm
作者
关键词
-
出版物
Frontiers in Bioengineering and Biotechnology
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-10-16
DOI
10.3389/fbioe.2020.588947
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Chemical Chaperones as Novel Drugs for Parkinson’s Disease
- (2020) Jordi Pujols et al. TRENDS IN MOLECULAR MEDICINE
- Inhibition of synucleinopathic seeding by rationally designed inhibitors
- (2020) Smriti Sangwan et al. eLife
- Long-term RNAi knockdown of α-synuclein in the adult rat substantia nigra without neurodegeneration
- (2019) Alevtina Zharikov et al. NEUROBIOLOGY OF DISEASE
- A pair of peptides inhibits seeding of the hormone transporter transthyretin into amyloid fibrils
- (2019) Lorena Saelices et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity
- (2019) Anita Carija et al. Redox Biology
- Novel Small Molecules Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein Protect Against Diverse α-Synuclein Mediated Dysfunctions
- (2019) Gergely Tóth et al. Scientific Reports
- Natural compound safranal driven inhibition and dis-aggregation of α-synuclein fibrils
- (2019) Shreyada S. Save et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- α-Synuclein strains target distinct brain regions and cell types
- (2019) Angus Lau et al. NATURE NEUROSCIENCE
- ZPD-2, a Small Compound That Inhibits α-Synuclein Amyloid Aggregation and Its Seeded Polymerization
- (2019) Samuel Peña-Díaz et al. Frontiers in Molecular Neuroscience
- A Protein Aggregation Inhibitor, Leuco-Methylthioninium Bis(Hydromethanesulfonate), Decreases α-Synuclein Inclusions in a Transgenic Mouse Model of Synucleinopathy
- (2018) Karima Schwab et al. Frontiers in Molecular Neuroscience
- Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson’s disease
- (2018) Gaia Faustini et al. ACTA NEUROPATHOLOGICA
- Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD
- (2018) Boris Kantor et al. MOLECULAR THERAPY
- Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons
- (2018) Jordi Pujols et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cryo-EM of full-length α-synuclein reveals fibril polymorphs with a common structural kernel
- (2018) Binsen Li et al. Nature Communications
- The E3 Ubiquitin Ligases TRIM17 and TRIM41 Modulate α-Synuclein Expression by Regulating ZSCAN21
- (2018) Iréna Lassot et al. Cell Reports
- High-Throughput Screening Methodology to Identify Alpha-Synuclein Aggregation Inhibitors
- (2017) Jordi Pujols et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Structure-based inhibitors of tau aggregation
- (2017) P. M. Seidler et al. Nature Chemistry
- α-Synuclein aggregation, seeding and inhibition by scyllo-inositol
- (2016) Tarek Ibrahim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Ade novocompound targeting α-synuclein improves deficits in models of Parkinson’s disease
- (2016) Wolfgang Wrasidlo et al. BRAIN
- Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
- (2016) Lars Tatenhorst et al. Acta Neuropathologica Communications
- Small Molecules Detected by Second-Harmonic Generation Modulate the Conformation of Monomeric α-Synuclein and Reduce Its Aggregation in Cells
- (2015) Ben Moree et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- What Can the Kinetics of Amyloid Fibril Formation Tell about Off-pathway Aggregation?
- (2015) Rosa Crespo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
- (2015) W. Peelaerts et al. NATURE
- Multiple-System Atrophy
- (2015) Alessandra Fanciulli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gallic acid interacts with α-synuclein to prevent the structural collapse necessary for its aggregation
- (2014) Yanqin Liu et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Anti-amyloid Compounds Inhibit α-Synuclein Aggregation Induced by Protein Misfolding Cyclic Amplification (PMCA)
- (2014) Maria Eugenia Herva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease
- (2013) Jens Wagner et al. ACTA NEUROPATHOLOGICA
- Protective Role of DNJ-27/ERdj5 in Caenorhabditis elegans Models of Human Neurodegenerative Diseases
- (2013) Fernando Muñoz-Lobato et al. ANTIOXIDANTS & REDOX SIGNALING
- Boosting chaperone-mediated autophagy in vivo mitigates α-synuclein-induced neurodegeneration
- (2013) Maria Xilouri et al. BRAIN
- Parkinson disease: from pathology to molecular disease mechanisms
- (2013) David T. Dexter et al. FREE RADICAL BIOLOGY AND MEDICINE
- Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease
- (2013) Silke Appel-Cresswell et al. MOVEMENT DISORDERS
- The Function of α-Synuclein
- (2013) Jacob T. Bendor et al. NEURON
- TFEB-mediated autophagy rescues midbrain dopamine neurons from -synuclein toxicity
- (2013) M. Decressac et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural and functional characterization of two alpha-synuclein strains
- (2013) Luc Bousset et al. Nature Communications
- Functional Analysis of VPS41-Mediated Neuroprotection in Caenorhabditis elegans and Mammalian Models of Parkinson's Disease
- (2012) A. J. Harrington et al. JOURNAL OF NEUROSCIENCE
- Pathological -Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
- (2012) K. C. Luk et al. SCIENCE
- Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts
- (2011) Lisa Fellner et al. ACTA NEUROPATHOLOGICA
- α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells
- (2011) Christian Hansen et al. JOURNAL OF CLINICAL INVESTIGATION
- Entacapone and Tolcapone, Two CatecholO-Methyltransferase Inhibitors, Block Fibril Formation of α-Synuclein and β-Amyloid and Protect against Amyloid-induced Toxicity
- (2010) Saviana Di Giovanni et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Baicalein reduces E46K α-synuclein aggregation in vitro and protects cells against E46K α-synuclein toxicity in cell models of familiar Parkinsonism
- (2010) Mali Jiang et al. JOURNAL OF NEUROCHEMISTRY
- EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
- (2010) Jan Bieschke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in -Synuclein Models of Parkinson's and Lewy Body Diseases
- (2009) B. Spencer et al. JOURNAL OF NEUROSCIENCE
- Curcumin inhibits aggregation of α-synuclein
- (2008) Neeraj Pandey et al. ACTA NEUROPATHOLOGICA
- Inhibition of α-Synuclein Fibrillization by Dopamine Is Mediated by Interactions with Five C-Terminal Residues and with E83 in the NAC Region
- (2008) Fernando E. Herrera et al. PLoS One
- Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model
- (2008) S. Hamamichi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- C. elegans Model Identifies Genetic Modifiers of α-Synuclein Inclusion Formation During Aging
- (2008) Tjakko J. van Ham et al. PLoS Genetics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started